​

Centessa Pharmaceuticals (CNTA) Stock Forecast, Price Target & Predictions

OverviewRevenueOwnershipFinancialsChart

CNTA Stock Forecast

Centessa Pharmaceuticals (CNTA) stock forecast, based on 14 Wall Street analysts, predicts a 12-month average price target of $39.17, with a high of $42.00 and a low of $35.00. This represents a -0.76% decline from the last price of $39.47.

$5 $13 $21 $29 $37 $45 High: $42 Avg: $39.17 Low: $35 Last Closed Price: $39.47

CNTA Stock Rating

Centessa Pharmaceuticals stock's rating consensus is Buy, based on 14 Wall Street analysts. The breakdown includes 0 Strong Buy (0.00%), 8 Buy (57.14%), 6 Hold (42.86%), 0 Sell (0.00%), and 0 Strong Sell (0.00%).

Buy
Total 14 0 6 8 Strong Sell Sell Hold Buy Strong Buy

CNTA Price Target Upside V Benchmarks

TypeNameUpside
StockCentessa Pharmaceuticals-0.76%
SectorHealthcare Stocks 15.45%
IndustryBiotech Stocks 41.48%

Price Target Trends

1M3M12M
# Anlaysts1311
Avg Price Target$42.00$40.00$33.18
Last Closing Price$39.47$39.47$39.47
Upside/Downside6.41%1.34%-15.94%
Ratings Trends
DateStrong BuyBuyHoldSellStrong SellTotal
Apr, 263124--19
Mar, 26312---15
Feb, 26311---14
Jan, 26311---14
Dec, 25311---14
Analyst Price Target Forecasts
DateAnalystCompanyPrice TargetPrice when PublishedPrice Target/Price when PublishedPrice Target/Last Closing Price
Apr 20, 2026Wells Fargo$42.00$39.665.90%6.41%
Feb 23, 2026Wolfe Research$40.00$25.4956.92%1.34%
Jan 29, 2026Truist Financial$38.00$24.7353.66%-3.72%
Jan 08, 2026Danielle BrillTruist Financial$33.00$22.6945.44%-16.39%
Jan 05, 2026Needham$38.00$23.6960.41%-3.72%
Dec 01, 2025Mayank MamtaniB.Riley Financial$42.00$28.7246.24%6.41%
Nov 05, 2025Danielle BrillTruist Financial$30.00$19.1556.66%-23.99%
Oct 28, 2025Sudan LoganathanStephens$35.00$24.4643.09%-11.33%
Sep 02, 2025Wells Fargo$31.00$17.2779.50%-21.46%
May 08, 2025Rudy LiChardan Capital$30.00$12.41141.74%-23.99%
Analyst Rating Forecasts
DateCompanyPrevious RatingNew RatingRating Change
Feb 23, 2026Wolfe ResearchOutperforminitialise
Jan 16, 2026Piper SandlerOverweightOverweighthold
Jan 14, 2026Cowen & Co.BuyBuyhold
Jan 05, 2026NeedhamBuyBuyhold
Dec 01, 2025B. RileyBuyBuyhold
Oct 28, 2025StephensOverweightinitialise
Sep 02, 2025Wells FargoOverweightinitialise
May 08, 2025OppenheimerOutperformOutperforminitialise
Nov 15, 2024GuggenheimBuyBuyhold
Sep 19, 2024Morgan StanleyEqual-WeightOverweightupgrade

Financial Forecast

EPS Forecast

Dec 23 Dec 24 Dec 25 Dec 26 Dec 27 Dec 28
Dec 23Dec 24Dec 25Dec 26Dec 27Dec 28
Reported$-1.57$-2.06$-1.46---
Avg Forecast$-1.63$-1.52$-1.55$-1.73$-2.03$-1.24
High Forecast$-1.57$-1.43$-1.12$-1.07$-1.11$-1.24
Low Forecast$-1.69$-1.78$-1.81$-2.00$-2.62$-1.24
Surprise %-3.68%35.53%-5.81%---

Revenue Forecast

$0 $30M $60M $90M $120M $150M Dec 23 Dec 24 Dec 25 Dec 26 Dec 27 Dec 28
Dec 23Dec 24Dec 25Dec 26Dec 27Dec 28
Reported$6.85M-----
Avg Forecast$6.85M$6.85M$269.50K$3.78M$40.90M$148.00M
High Forecast$6.85M$6.85M$269.75K$3.78M$40.90M$148.00M
Low Forecast$6.85M$6.85M$269.25K$3.78M$40.90M$148.00M
Surprise %------

Net Income Forecast

$-300M $-260M $-220M $-180M $-140M $-100M Dec 23 Dec 24 Dec 25 Dec 26 Dec 27 Dec 28
Dec 23Dec 24Dec 25Dec 26Dec 27Dec 28
Reported$-151.09M$-235.76M$-197.53M---
Avg Forecast$-151.09M$-161.26M$-141.22M$-147.35M$-251.32M$-118.94M
High Forecast$-150.62M$-137.35M$-108.02M$-102.63M$-106.36M$-118.94M
Low Forecast$-162.13M$-171.23M$-174.41M$-192.06M$-251.91M$-118.94M
Surprise %-46.19%39.88%---

CNTA Forecast FAQ

Is Centessa Pharmaceuticals stock a buy?

Centessa Pharmaceuticals stock has a consensus rating of Buy, based on 14 Wall Street analysts. The rating breakdown includes 0 Strong Buy, 8 Buy, 6 Hold, 0 Sell, and 0 Strong Sell, reflecting a consensus that Centessa Pharmaceuticals is a favorable investment for most analysts.

What is Centessa Pharmaceuticals's price target?

Centessa Pharmaceuticals's price target, set by 14 Wall Street analysts, averages $39.17 over the next 12 months. The price target range spans from $35 at the low end to $42 at the high end, suggesting a potential -0.76% change from the previous closing price of $39.47.

How does Centessa Pharmaceuticals stock forecast compare to its benchmarks?

Centessa Pharmaceuticals's stock forecast shows a -0.76% downside, underperforming the average forecast for the healthcare stocks sector (15.45%) and underperforming the biotech stocks industry (41.48%).

What is the breakdown of analyst ratings for Centessa Pharmaceuticals over the past three months?

  • April 2026: 15.79% Strong Buy, 63.16% Buy, 21.05% Hold, 0% Sell, 0% Strong Sell.
  • March 2026: 20.00% Strong Buy, 80.00% Buy, 0% Hold, 0% Sell, 0% Strong Sell.
  • February 2026: 21.43% Strong Buy, 78.57% Buy, 0% Hold, 0% Sell, 0% Strong Sell.

What is Centessa Pharmaceuticals’s EPS forecast?

Centessa Pharmaceuticals's average annual EPS forecast for its fiscal year ending in December 2026 is $-1.73, marking a 18.49% increase from the reported $-1.46 in 2025. Estimates for the following years are $-2.03 in 2027, and $-1.24 in 2028.

What is Centessa Pharmaceuticals’s revenue forecast?

Centessa Pharmaceuticals's average annual revenue forecast for its fiscal year ending in December 2026 is $3.78M, reflecting a 0% decrease from the reported $0 in 2025. The forecast for 2027 is $40.9M, and $148M for 2028.

What is Centessa Pharmaceuticals’s net income forecast?

Centessa Pharmaceuticals's net income forecast for the fiscal year ending in December 2026 stands at $-147M, representing a -25.41% decrease from the reported $-198M in 2025. Projections indicate $-251M in 2027, and $-119M in 2028.